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Abstract 
Background:To determine the frequency and 
assess the clinic-pathological presentation of 
mucoepidermoid carcinoma (MEC). 
Methods: In this cross-sectional study, all the cases 
 of malignant salivary gland tumours were included. 
Out of these the frequency of mucoepidermoid 
carcinoma was noted. The data analysis included the 
age, gender, anatomical site of tumour and its 
histopathological grading. 
Results:A total of 68 malignant salivary gland 
tumors presented to the department of 
histopathology.Out of these, 44% were diagnosed as 
mucoepidermoid carcinomas. The age ranged from 
17 years to 88 years(mean age 44 years).Male patients 
were 21 out of 30, with overall male to female ratio of 
1:0.43. Majority (73.3%) occurred in parotid gland, 
10% in sub mandibular glands and 16.6 % in minor 
salivary glands. Based on histopathological grading, 
33.3% were high grade, 23.3% were intermediate 
grade and 43.3%  were low grade MEC. 
Conclusion: Frequency of mucoepidermoid 
carcinoma was 44% among all salivary gland 
malignancies with more than half of the tumors 
originating in parotid gland. Histopathologically low 
grade type (43.3%) was the commonest. 
Key Words: Salivary Glands, Mucoepidermoid 
Carcinoma, Malignant. 
 
Introduction 
    Tumours of salivary glands constitute  5% of the 
head and neck malignancies.1 Prevalence of MEC 
among salivary gland tumours reported in Pakistan is 
around 9.5-25.6% and is considered to be the most 
common malignancy of salivary glands.2,3 World wide 
prevalence of the MEC is 12-40%.4  In the excretory 
duct of salivary gland, it is presumed to be  arising  
from reserve cells and comprised of epidermoid, 
intermediate and mucous cells. 6,7 MEC has a 
predilection for adults in their fourth to sixth decade 
with the highest prevalence noticed during the fifth 
decade of life.2,4,7  It most commonly affects the major 
salivary glands with parotid taking the lead among the 
major salivary glands having an incidence of about 45-
56.9%. 4,6 Next common site is the minor salivary 
glands with an incidence of 22.9-37.1% , where most 
common site is palate.5,8,9 
    Clinically MEC usually presents as a slow growing 
and long standing painless swelling. Pain and 
ulceration is usually seen in aggressive MEC especially 
when it involves the facial nerve.7 Auclair et al and 
Goode et al described a reproducible histologic 
grading system for MEC and described MEC as low 
grade, intermediate grade and high grade malignancy 
using five histopathological features namely, 
intracystic component, neural invasion, necrosis, 
mitosis and anaplasia.9  
               
Patients  and Methods 
     All the malignant salivary gland tumors which 
were presented to the histopathology department of 
AFIP, Rawalpindi from 1st Jan 2010 to 31st Dec 2013 
were included. Out of these, tumors with a diagnosis 
of Mucoepidermoid carcinoma were further analyzed. 
 Fresh hematoxylin and eosin (H&E) stained slides 
were prepared and histopathological pattern was 
reconfirmed. The age, gender and anatomic location of 
tumor were noted as described in the records and the 
samples with incomplete record or with necrosed, 
scanty and autolysed tissue were excluded. Frequency 
and percentages were calculated for the quantitative 
variables using statistical software SPSS 17.0. 
 
Results 
  Out of 68 malignant salivary gland tumours, 30 were 
diagnosed as mucoepidermoid carcinomas with an 
overall frequency of 44% among the salivary gland 
malignancies. Mean age of the patients of MEC was 
44.27 years (range17 - 88 years). Nine cases (30%) were 
found in age below 30 years s and 5 cases (16.7%) were 
found above 60 years.(Table 1). Mean age for patients 
with high grade malignancy was 54.6 years, for 
intermediate grade MEC 41.2 years and for low grade 
tumours mean age seen was 37.9 years . Twenty one 
out of 30 cases were male with an overall male to 
female ratio of 1:0.43 . Majority (73.3%) occurred in 
parotid gland. Among the tumours occurring in minor 
salivary glands, palate was the most common site 
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(13.3%)(Table 2). High grade tumours were seen 
mostly in patients with an age group more than 50 
years (Table3).Ten (33.3%) were high grade, 7 (23.3%) 
intermediate grade and 13 (43.3%) were classified as 
low grade malignancies (Table 4 & 5).  Low grade 
MEC revealed mucous secreting epidermoid cells with 
no cellular pleomorphism (Figure 1). High grade 
tumours showed epidermoid cell predominance with 
nuclear and cellular pleomorphism (Figure 2) 
 
Table 1: Mucoepidermoid Carcinoma-Age 
distribution 
Age (years) Number  Percentage  
Below 30 9 30 
30 – 60 16 53.3 
Above 60 5 16.7 
Total 30 100.0 
 
Table 2:  Mucoepidermoid Carcinoma- Sites 
Site of MEC No Percentage  
Parotid Gland 22 73.3 
Sub Mandibular Gland 3 10.0 
Minor salivary glands 5 16.7 
Total 30 100.0 
 
Table 3 : Mean age of different grades of MECs 
Grades of MECs Percentage Mean age 
Low grade MECs 43.3 37.9 
Intermediate grade MECs 23.3 41.2 
High grade MECs 33.3 54.6 
 
Table 4:Relation between gender and 
histopathological grades of MEC 
Histopathological 
Grade 
Male Female p value 
(Fishers exact 
test) 
High grade MEC 
(n=10)  
7 3 0.700 
Intermediate grade 
MEC (n=7) 
4 3 0.700 
Low grade 
MEC(n=13) 
10 3 0.700 
 
Table 5: Proportion of different grades of MECs 
in the sample population (n=30) 
Histological Grades Number Percentage 
High 10 33.3 
Intermediate 7 23.3 
Low 13 43.3 
 
 
 
 
 
 
 
 
 
Figure 1:Low Grade MEC showing mucus-secreting 
and epidermoid cells predominate and there is no 
cellular pleomorphism (H&E; low power view) 
 
 
 
 
 
 
 
 
Figure 2:High Grade MEC  showing epidermoid and 
intermediate cells predominance with nuclear and 
cellular pleomorphism, and nuclear 
hyperchromatism (H& E; low power view). 
 
Discussion 
     Salivary gland tumors account for almost 5% of the 
head and neck malignancies and among these, 
Mucoepidermoid carcinoma is considered the most 
common malignancy of major and minor salivary 
glands. MEC is thought to arise from pluripotent 
reserve cells of the excretory ducts of salivary glands 
that have the potential to differentiate into squamous, 
columnar and mucous cells. These tumours consist of 
epidermoid cells, mucous cells and poorly 
differentiated intermediate cells with growth pattern 
ranging from cystic to solid to infiltrative. 1-5  
  Auclair et al and Goode et al described a 
reproducible histologic grading system for MEC and 
described MEC as low grade, intermediate grade and 
high grade malignancy using five histopathologic 
features namely, intracystic component, neural 
invasion, necrosis, mitosis and anaplasia.9 Low grade 
tumors are well demarcated and exhibit pushing 
margins and dilated cystic spaces containing mucinous 
material. Intermediate grade MEC comprise of solid 
rather than cystic architecture with more intermediate 
cells than mucinous cells. In high grade MEC features 
seen are infiltrative border, anaplasia, necrosis, 
atypical mitoses, perineural and lymphatic invasion.3,6-
9 Low grade MEC are usually treated by local surgical 
excision where as in high grade MEC wide surgical 
excision, neck dissection and post op radiotherapy is 
required for loco-regional disease control.7 
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 Differentiation of MEC in low grade, intermediate 
grade and high grade is at times difficult especially the 
differentiation between intermediate grade and high 
grade and between high grade MEC and poorly 
differentiated squamous cell carcinoma. 
Histopathological grading is an important prognostic 
factor regarding 5 years survival outcome (92-100% in 
low grade, 62-93% in intermediate grade and 0-43% in 
high grade. 8 
   In present  analysis of 68 cases of salivary gland 
malignancy, frequency of mucoepidermoid carcinoma 
was seen to be 44%. This is comparable to a study from 
Karachi , whereas studies from, Rawalpindi, Lahore, 
China and Italy have depicted a lesser frequency of 
mucoepidermoid carcinoma among all the salivary 
gland malignancies.2,4,5,10.14 The mean age of 
presentation in our study sample was 44.27 years. This 
fact has also been reported by authors from Karachi, 
Lahore, Brazil, Rawalpindi, and New York, while 
authors from Greece and Japan report sixth and 
seventh decade to be the mean age in their population 
respectively. 3,4,5,8,9,11,12 It was seen that mean age for 
high grade tumors was significantly higher (54.6 years) 
as compared to low grade tumors (37.9 years) showing 
that patients with increasing age more prone to get 
high grade malignancy as compared to younger age. 
Similar findings have been reported by Nance et al. 7 
There was male predilection of mucoepidermoid 
carcinoma  (male to female ratio of 1:0.43).This is in 
accordance with study of Rapidis et al. In contrast 
Rahman et al  reported a female predilection. 5,12 
   Most commonly involved salivary gland was parotid 
(73.3%). The next most common location was minor 
salivary glands (16.7%). Very small percentage 
affected the submandibular gland (10%) . This finding 
is in harmony with studies by Qureshi et al, 
Brandwein et al, Rapidis et al and Gill et al.2,4,11,12 Pires 
et al, Tian et al and Kokemueller et al  reported minor 
salivary glands were the most common location for 
MEC in their respective groups followed by parotid 
gland as the second most common site.8,10.13 Palate was 
the most common location (13.3%), this fact has also 
been supported by other studies from various 
authors.5,8,9,11,14,15   
 
Conclusion 
1.Mucoepidermoid carcinoma is the commonest 
salivary gland malignancy in our set up accounting 
for almost half of these salivary gland 
malignancies.  
2.Mean age of presentation is in the fifth decade 
and male predilection was observed.  
3.The most common site is parotid followed by 
minor salivary glands.  
4. According to  histopathological pattern low 
grade variety is most commonly seen. 
  
References 
1. Ali SS, Memon AS, Shaik NA, Soomro AG. Mucoepidermoid 
carcinoma of parotid presenting as unilocular cyst. J Ayub 
Med Coll Abbottabad.2008;20(2):141-43.  
2. Din I, Bukhari MH, Hamid T, Zaman S. Incidence of salivary 
gland tumors: a morphological study. Ann King Edward Med 
Coll. 2006;12(1):161-63 
3. Qureshi A, Rehman K, Hussain S, Khawaja NH. Salivary 
gland tumors - a three years’ experience. Ann King Edward 
Med Coll. 2004;10(2):200-03 
4. Gill MS, Muzaffar S, Soomro IN, Kayani N. Morphological 
patterns of salivary gland tumours. J Pak Med Assoc. 
2001;51(10):343-46.  
5. Rahman B, Mamoon N, Jamal S, Zaib N. Malignant tumours 
of the minor salivary glands in Northern Pakistan. Hematol 
Oncol Stem Cell Ther. 2008;1(2):90-93. 
6. Ozawa H, Tomita T, Sakamoto K, Tagawa T. 
Mucoepidermoid carcinoma of the head and neck: clinical 
analysis of 43 patients. Japan J Clin Oncol. 2008;38(6):414-
18 
7. Nance MA, Seethala RR, Wang Y, Chiosea SI. Treatment and 
survival outcomes based on histologic grading in patients 
with head and neck mucoepidermoid carcinoma. Cancer. 
2008;11(3):2082-89. 
8. Pires FR, de Almeida OP, de Araújo VC, Kowalski LP. 
Prognostic factors in head and neck mucoepidermoid 
carcinoma. Arch Otolaryngol Head Neck Surg. 
2004;130(2):174-80.  
9. Okabe M, Inagaki H, Murase T, Inoue M, Nagai N. 
Prognostic significance of p27 and Ki-67 expression in 
mucoepidermoid carcinoma of the intraoral minor salivary 
gland. Mod Pathol. 2001;14(10):1008-14.  
10. Tian Z, Li L, Wang L, Hu Y, Li J. Salivary gland neoplasms in 
oral and maxillofacial regions: a 23 year retrospective study 
of 6982 cases in an eastern Chinese population. Int J Oral 
Maxillofac Surg. 2010;39(3):235-42.  
11. Brandwein MS, Ivanov K, Wallace DI, Hille JJ. 
Mucoepidermoid Carcinoma: a clinicopathologic study of 80 
patients with special reference to histological grading. Am J 
Surg Pathol. 2001;25(7):835-45.  
12. Rapidis AD, Givalos N, Gakiopoulou H, Stavrianos SD. 
Mucoepidermoid carcinoma of the salivary glands. Review 
of the literature and clinicopathological analysis. Oral 
Oncol. 2007;43(2):130-36.  
13. Kokemueller H, Brueggemann N, Swennen G, Eckardt A.  
Mucoepidermoid carcinoma of the salivary glands--clinical 
review of 42 cases. Oral Oncol. 2005;41(1):3-10.  
14. Copelli C, Bianchi B, Ferrari S, Ferri A, Sesenna E. Malignant 
tumors of intraoral minor salivary glands. Oral Oncol. 
2008;44(7):658-63.  
15. Subhashraj K. Salivary gland tumours: a single institution 
experience. Br J Oral Maxillofac Surg. 2008;46(8):635-38.  
16. Moshy J, Mwakyoma H, Owibingire S. Intra oral Minor 
salivary gland neoplasms; The pattern and management. 
Professional Med J. 2010;17:483-89.  
17. Leong SCL, Pinder E, Sasse R. Mucoepidermoid carcinoma of 
the tongue. Singapore Med J. 2007;48:e272-74.  
18. Van der Waal JE, Snow GB, van der Waal I. Histological 
reclassification of 101 intra oral salivary gland tumors (new 
WHO classification). J Clin Pathol. 1992;45(9):834-36.  
 
